Arktus Therapeutics Co., Ltd.
PrivateLast Round
Series A
Sep 22, 2025
Total Funding Raised
$7.32M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Arktus Therapeutics Co., Ltd. is a biotechnology company that develops regenerative medicine for knee cartilage repair using iPS cell and 3D-printing technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, 3D Printing, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arktus Therapeutics Co., Ltd. Comparables
Compare Arktus Therapeutics Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BIONCaRT GmbH | 79% | |
| Sumitomo Chemical | 76% | |
| Teijin Limited | 72% |
Arktus Therapeutics Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 22, 2025 | ||||
| Seed | Apr 10, 2024 |
Arktus Therapeutics Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chushin Venture Capital | Series A |
| Kyoto Capital Partners | Seed, Series A |
| QB Capital | Seed, Series A |
| 株式会社佐銀キャピタル＆コンサルティング | Seed, Series A |
| Kyoto University Innovation Capital | Series A, Seed |
| Japan Science and Technology Agency | Seed, Series A |
| MTG Ventures, Inc. | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 22, 2025
Raised $4.46M from multiple venture capital firms.
- Apr 10, 2024
$2.86M round led by Kyoto University Innovation Capital
Arktus Therapeutics Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Arktus Therapeutics Co., Ltd.'s valuation, stock price, and market status.
Is Arktus Therapeutics Co., Ltd. a public or private company?
Arktus Therapeutics Co., Ltd. is a private company.
What is the current stock price of Arktus Therapeutics Co., Ltd.?
Arktus Therapeutics Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Arktus Therapeutics Co., Ltd. worth (valuation)?
Valuation information for Arktus Therapeutics Co., Ltd. is not publicly available.
Can I buy Arktus Therapeutics Co., Ltd. stock?
Arktus Therapeutics Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Arktus Therapeutics Co., Ltd.'s last funding round?
Arktus Therapeutics Co., Ltd.'s most recent funding round was Series A on September 22, 2025.
Who are the main investors in Arktus Therapeutics Co., Ltd.?
Key investors in Arktus Therapeutics Co., Ltd. include Kyoto University Innovation Capital.
Will Arktus Therapeutics Co., Ltd. IPO soon?
No public IPO plans have been announced for Arktus Therapeutics Co., Ltd..
How can I track Arktus Therapeutics Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Arktus Therapeutics Co., Ltd.'s secondary market activity and sign up for updates.